Harrison D E, Astle C M, Lerner C
J Exp Med. 1984 Sep 1;160(3):759-71. doi: 10.1084/jem.160.3.759.
Erythropoietic repopulating abilities of fetal liver cells and young and old adult marrow cells were compared as follows: Equal numbers of cells from a donor of each age were mixed with a constant portion of cells pooled from genetically distinguishable competitors. These mixtures were transplanted into stem cell-depleted recipients, and the proportions of recipient hemoglobin that were donor type measured the relative effectiveness of early erythropoietic precursor cells from the various donors (Fig. 1). At intervals of 3-6 mo, recipients were sublethally irradiated, requiring a new round of competitive repopulation. When B6 mice were used as donors, with WBB6F1 competitors and recipients, the highest levels of stem cell activity were found using old donors (Tables I, III). This was true even with unirradiated, immune-competent W/Wv recipients (Table III). When donors and recipients were WBB6F1 hybrids, with B6 competitors, fetal cells initially gave higher levels of repopulating ability, and they were similar to the adult and old marrow cells after 400 d and after recovery from two sublethal irradiations (Table II). These effects were mostly insignificant and probably reflect small differences in initial stem cell concentrations that are brought out by the sensitivity of the competitive repopulation assay. Clearly, ultimate erythropoietic stem cell proliferative capacities did not decline as a result of the proliferation required between 15 d of fetal life and old age. Repopulating abilities of 12-d fetal liver cells were not detectable. We also showed that the proportions of newly synthesized hemoglobins made by the two types of stem cells in tetraparental mice remained nearly constant when tested at 3-d intervals over 30 d. Minimum numbers of stem cells producing erythrocytes over a single 3-d period were calculated as 62 and 128, but these are too low, since variances were similar in the tetraparental mice and in the F1 hybrid control. This contradicts the hypothesis that erythropoietic stem cells reserve limited proliferative capacities by proliferating one or a few at a time. We suggest that erythropoietic stem cells have essentially unlimited proliferative capacities and are found in approximately equal concentrations in the primary erythropoietic organs after 15 or 16 d of fetal life.
将来自每个年龄段供体的等量细胞与从基因可区分的竞争细胞中汇集的恒定比例的细胞混合。这些混合物被移植到干细胞耗尽的受体中,受体血红蛋白中供体类型的比例衡量了来自不同供体的早期红细胞生成前体细胞的相对有效性(图1)。每隔3 - 6个月,对受体进行亚致死剂量照射,这需要新一轮的竞争性再填充。当使用B6小鼠作为供体,WBB6F1小鼠作为竞争细胞和受体时,发现老龄供体的干细胞活性水平最高(表I、III)。即使对于未照射的、具有免疫能力的W/Wv受体也是如此(表III)。当供体和受体均为WBB6F1杂种小鼠,B6小鼠作为竞争细胞时,胎儿细胞最初具有较高的再填充能力水平,在400天后以及从两次亚致死剂量照射恢复后,它们与成年和老龄骨髓细胞的再填充能力相似(表II)。这些影响大多不显著,可能反映了竞争再填充试验的敏感性所揭示的初始干细胞浓度的微小差异。显然,最终的红细胞生成干细胞增殖能力不会因胎儿期15天到老年期所需的增殖而下降。12天胎儿肝细胞的再填充能力无法检测到。我们还表明,在四亲代小鼠中,两种类型的干细胞产生的新合成血红蛋白的比例在30天内每隔3天进行测试时几乎保持恒定。计算得出在单个3天期间产生红细胞的干细胞的最小数量为62和128,但这些数值过低,因为四亲代小鼠和F1杂种对照中的方差相似。这与红细胞生成干细胞通过一次增殖一个或几个来保留有限增殖能力的假设相矛盾。我们认为,红细胞生成干细胞具有基本无限的增殖能力,并且在胎儿期15或16天后在主要红细胞生成器官中的浓度大致相等。